GenMark Diagnostics Inc (NASDAQ:GNMK)

6.22
Delayed Data
As of 2:28pm ET
 +0.06 / +0.97%
Today’s Change
3.63
Today|||52-Week Range
13.67
+49.16%
Year-to-Date
No recent news for GenMark Diagnostics Inc.

Today’s Trading

Previous close6.16
Today’s open6.12
Day’s range6.09 - 6.40
Volume87,766
Average volume (3 months)398,354
Market cap$273.1M
Data as of 2:28pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-5.22%
Earnings growth (this year)+34.40%
Earnings growth (next 5 years)-45.29%
Revenue growth (last year)+6.59%
P/E ratioNM
Price/Sales4.06
Price/Book3.87

Competitors

 Today’s
change
Today’s
% change
ATRSAntares Pharma Inc-0.03-1.28%
TCMDTactile Systems Tech...-0.22-0.63%
ANGOAngioDynamics Inc-0.16-0.79%
CRYCryoLife Inc+0.10+0.43%
Data as of 2:46pm ET, 04/20/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$52.5M
Annual profit (last year)-$61.9M
Net profit margin-117.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Hany Massarany
Senior Vice President-
Operations
Brian Mitchell
Corporate headquarters
Carlsbad, California

Forecasts